focus -WSS

focus

author：focus 2025-09-05 11:28:03 - browse：952

King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT — Pat Greenhouse/Globe Staff

MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

WSS

Chimpanzees, like humans and whales, get menopause: Study

Menendez indictment could see pharma lose a key ally

Shingles, which affected Dianne Feinstein, is on the rise

FDA seeks to regulate lab

Biogen shutters digital health group, ends Apple study, in cost cutting move

Would Medicare drug price negotiations stall in a shutdown?

leisure time

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

United colonoscopy coverage change 'may cost lives,' doctors say

Why do women spend more than men on medical expenses?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Researchers use wearables data and AI to predict preterm birth risk

Alkermes shareholders re

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

The high cost of giving birth even with insurance

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Wikipedia

Testing for cancer recurrence creates a new limbo for patients

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Intercept Pharmaceuticals sells itself for less than $1 billion

Medicaid, Medicare dual

Readout Newsletter: New research from Sanofi, Regeneron, etc.

FDA advisers vote against ALS treatment from BrainStorm

leisure time

focus

knowledge

leisure time